Earnings release

Moderna, Inc. Moderna, Inc. · 2026 Q2

ReportedJul 31, 2026
Period endedJun 30, 2026
Rule of 40-386

Consensus vs reported

EPS IN LINE
-$1.97
vs -$1.97 expected
QoQ+42.1%
YoY+7.5%
Revenue BEAT +14%
$145M
vs $126.7M expected
QoQ-62.7%
YoY+2.1%

QoQ and YoY are measured on the same basis as each panel's own consensus, so no panel compares two different measures.

2026 Q2 preview

Reported this quarter

Each tile opens the full quarterly series. Download the numbers as CSV or JSON.

Coverage around this release

Estimate against reported

$0.54-$1.69-$3.912024 Q3 reported $0.032024 Q32024 Q4 reported -$2.912024 Q42025 Q1 reported -$2.522025 Q12025 Q2 reported -$2.132025 Q22025 Q3 reported -$0.512025 Q32025 Q4 reported -$2.112025 Q42026 Q1 reported -$3.402026 Q12026 Q2 estimate -$1.972026 Q2 reported -$1.972026 Q2
Our published estimate Reported EPS
QuarterEstimateReportedSurprise
2024 Q3 $0.03
2024 Q4 -$2.91
2025 Q1 -$2.52
2025 Q2 -$2.13
2025 Q3 -$0.51
2025 Q4 -$2.11
2026 Q1 -$3.40
2026 Q2 -$1.97 -$1.97 +0%

Estimates are the consensus we published on our own preview for that quarter; quarters we did not preview carry the reported figure only. Where a consensus was set on a non-GAAP basis, the reported column shows that same measure.

Sources & downloads

Company Published by the company on the day of the release.
HTML Earnings press release Investor relations announcement

2026 Q2 across the sector

Every MRNA quarter